RESTASIS .5 mg/mL

RESTASIS .5 mg/mL is an ophthalmic emulsion containing cyclosporine. It is designed to help increase tear production in individuals with chronic dry eye disease. This prescription treatment aims to improve eye comfort and reduce dryness.

RESTASIS .5 mg/mL is primarily used to treat chronic dry eye disease. It works by increasing the production of tears, which can help alleviate symptoms such as dryness, irritation, and discomfort. This medication is often recommended for individuals who experience persistent dry eye symptoms that do not respond to artificial tears or other over-the-counter treatments.

Common effects of RESTASIS .5 mg/mL may include temporary burning or stinging upon application. Some users may also experience redness or itching in the eyes. These effects are usually mild and transient, but if they persist or worsen, it is advisable to consult a healthcare professional.

RESTASIS .5 mg/mL should be handled with care to avoid contamination. The single-use vials should not be reused. It is important to follow proper hygiene practices when administering the emulsion. Individuals with a history of eye infections or other eye conditions should use this medication under the guidance of a healthcare professional.

RESTASIS .5 mg/mL may interact with other ophthalmic medications. It is advisable to inform your healthcare provider about all medications you are currently using. Additionally, avoid using contact lenses while applying this medication, as it may cause irritation or discomfort.